AtaiBeckley (ATAI) Shares Outstanding (2020 - 2026)
AtaiBeckley (ATAI) posted quarterly Shares Outstanding (Entity) of $365.6 million for Q1 2026, up 82.99% year-over-year from $199.8 million in Q1 2025, and up 61.37% quarter-over-quarter from $226.5 million in Q4 2025.
AtaiBeckley (ATAI) Shares Outstanding (2020 - 2026) Analysis & Trends
AtaiBeckley's Shares Outstanding (Entity) history runs 3 years deep, the most recent figure standing at $365.6 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 82.99% year-over-year to $365.6 million; the TTM figure through Mar 2026 stood at $365.6 million (up 82.99% YoY), while the FY2025 annual figure was $226.5 million, up 34.87% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $365.6 million, up from $226.5 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $240.4 million in Q3 2025 and troughed at $137.6 million in Q1 2021.
- A 5-year average of $171.2 million and a median of $166.0 million in 2023 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Entity) surged 34.87% in 2025, then soared 82.99% in 2026.
- AtaiBeckley's Shares Outstanding (Entity) stood at $168.0 million in 2024, then jumped by 34.87% to $226.5 million in 2025, then soared by 61.37% to $365.6 million in 2026.
- Business Quant data shows ATAI's Shares Outstanding (Entity) at $365.6 million in Q1 2026, $226.5 million in Q4 2025, and $199.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | AtaiBeckley | 2.69 Bn | 2.69 Bn | - | 217.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 360.75 Mn |
| Mar 31, 2026 | 357.42 Mn |
| Dec 31, 2025 | 226.53 Mn |
| Sep 30, 2025 | 217.60 Mn |
| Jun 30, 2025 | 196.56 Mn |
| Mar 31, 2025 | 176.27 Mn |
| Mar 31, 2025 | 176.27 Mn |
| Dec 31, 2024 | 160.16 Mn |
| Dec 31, 2024 | 160.16 Mn |
| Sep 30, 2024 | 160.62 Mn |
| Jun 30, 2024 | 160.39 Mn |
| Mar 31, 2024 | 158.89 Mn |
| Dec 31, 2023 | 158.83 Mn |
| Sep 30, 2023 | 155.79 Mn |
| Jun 30, 2023 | 155.79 Mn |
| Mar 31, 2023 | 155.79 Mn |
| Dec 31, 2022 | 155.72 Mn |
| Sep 30, 2022 | 156.61 Mn |
| Jun 30, 2022 | 153.97 Mn |
| Mar 31, 2022 | 153.53 Mn |